Literature DB >> 30473554

A novel compound heterozygous mutation in the GJB2 gene is associated with non-syndromic hearing loss in a Chinese family.

Haiou Jiang1, Youya Niu1, Lingfeng Qu1, Xueshuang Huang1, Xinlong Zhu1, Genyun Tang1.   

Abstract

Autosomal recessive (AR) non-syndromic hearing loss (NSHL) is the most common form of hereditary deafness. Mutations in the gap junction protein beta 2 (GJB2) gene encoding connexin 26 (Cx26) account for about 50% of cases of ARNSHL. In the current study, a combination of exome sequencing and Sanger sequencing in a Chinese Dong family with ARNSHL allowed identification of a novel compound heterozygous mutation c.240G>C(p. Q80H)/C.109G>A(p.V37I) in exon 2 of the GJB2 gene, which co-segregated with the disease phenotype in this family and was not evident in 100 healthy controls. Bioinformatic analysis revealed that the two mutations in the GJB2 gene were probably pathogenic. Results indicated that the compound heterozygous variants, p.Q80H and p.V37I, in the GJB2 gene are associated with ARNSHL. The Q80H variant was initially identified in patients of Dong Chinese origin with NSHL. The current results broaden the spectrum of GJB2 mutations responsible for NSHL and have important implications for molecular diagnosis, treatment, and genetic counseling for this family.

Entities:  

Keywords:  Exome sequencing; GJB2 gene; hearing loss; mutation

Mesh:

Substances:

Year:  2018        PMID: 30473554     DOI: 10.5582/bst.2018.01156

Source DB:  PubMed          Journal:  Biosci Trends        ISSN: 1881-7815            Impact factor:   2.400


  2 in total

1.  Hearing Phenotypes of Patients with Hearing Loss Homozygous for the GJB2 c.235delc Mutation.

Authors:  Chang Guo; Sha-Sha Huang; Yong-Yi Yuan; Ying Zhou; Ning Wang; Dong-Yang Kang; Su-Yan Yang; Xin Zhang; Xue Gao; Pu Dai
Journal:  Neural Plast       Date:  2020-08-01       Impact factor: 3.599

2.  GJB2 mutations in Iranian Azeri population with autosomal recessive nonsyndromic hearing loss (ARNSHL): First report of c.238 C>A mutation in Iran.

Authors:  Ehsan Abbaspour Rodbaneh; Mohammad Panahi; Bahareh Rahimi; Haleh Mokabber; Reza Farajollahi; Behzad Davarnia
Journal:  J Clin Lab Anal       Date:  2021-09-28       Impact factor: 2.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.